NCT07334145尚未招募不适用
Effect of SGLT2 Inhibitors On Anemia in Patients With Chronic Kidney Disease (CKD)
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- hemoglobin level
研究概览
简要总结
anemia is a common complication of CKD patients and affect the quality of life and increase morbidity and mortality. managing anemia in CKD patients remains challenging conventional therapy including iron and ESAs which has its complications. the SGLT2 inhibitors have emerging evidence from major clinical trials in improving anemia in patients with CKD
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age more than 18 years
- •CKD stage 1_4
- •baseline hemoglobin 8.5 to 12.9 g/dl
- •stable anemia regimen for more than 8 weeks
排除标准
- •dialysis recent blood transfusion or ESA dose change within 8 weeks active malignancy or infection pregnancy or lactation history of recurrent DKA or sever volume depletion
研究组 & 干预措施
CKD patients stage 1_4
干预措施: SGLT2 inhibitor (Drug)
结局指标
主要结局
hemoglobin level
时间窗: 12 weeks
use the hemoglobin level to assist the effect of SGLT2 inhibitors On anemia correction
change in hemoglobin level
时间窗: 12 weeks
anemia correction
次要结局
未报告次要终点
研究者
Romany Nageb
resident of internal medicine at sohag university hospital
Sohag University
研究点 (1)
Loading locations...
相似试验
招募中
4 期
SGLT2 inhibition in addition to lifestyle intervention and risk for
complications in subtypes of patients with prediabetes - a
randomized, placebo controlled, multi-center trial2024-512179-11-00Universitaetsklinikum Tuebingen AöR182
已完成
不适用
Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease PatientsDiabetesChronic Kidney DiseaseNCT07302464Ain Shams University60
招募中
3 期
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney DiseaseNCT07280585University of Cologne420
招募中
不适用
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKDDiabetes Mellitus, Type 2ObesityNCT07309094Cardenal Herrera University250
已完成
不适用
Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene (APOL1)NCT07288723Centre Hospitalier Universitaire de la Guadeloupe88